These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38178941)

  • 1. Use of ivermectin and factors associated with the prevention and/or treatment of COVID-19: a cross-sectional online survey in the province of Chincha, Peru.
    Salvador-Carrillo J; Campos-Loza L; Guillen-Carbajal D; Osada J; Zevallos A; Torres-Roman JS
    F1000Res; 2023; 12():149. PubMed ID: 38178941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.
    Garcia PJ; Mundaca H; Ugarte-Gil C; Leon P; Malaga G; Chaccour C; Carcamo CP
    Trials; 2021 Apr; 22(1):262. PubMed ID: 33836826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of medicinal plants for COVID-19 prevention and respiratory symptom treatment during the pandemic in Cusco, Peru: A cross-sectional survey.
    Villena-Tejada M; Vera-Ferchau I; Cardona-Rivero A; Zamalloa-Cornejo R; Quispe-Florez M; Frisancho-Triveño Z; Abarca-Meléndez RC; Alvarez-Sucari SG; Mejia CR; Yañez JA
    PLoS One; 2021; 16(9):e0257165. PubMed ID: 34550994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ivermectin for preventing and treating COVID-19.
    Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 seroprevalence on the north coast of Peru: A cross-sectional study after the first wave.
    Moyano LM; Toledo AK; Chirinos J; Vilchez Barreto PMQ; Cavalcanti S; Gamboa R; Ypanaque J; Meza M; Noriega S; Herrera V; Bazan E; Requena A; Silva H; Burgos H; León-Jimenez F;
    PLoS Negl Trop Dis; 2023 Jun; 17(6):e0010794. PubMed ID: 37379355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and factors associated with food insecurity in eight high-altitude cities in Peru during the second wave of the COVID-19 pandemic: a retrospective, cross-sectional study.
    Zila-Velasque JP; Grados-Espinoza P; Quispe-Chura K; Valdiviezo-Morales CG; Diaz-Vélez C; Valladares-Garrido MJ
    BMC Public Health; 2022 Oct; 22(1):1962. PubMed ID: 36284287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Peru in July and August, 2020: a population-based study.
    Álvarez-Antonio C; Meza-Sánchez G; Calampa C; Casanova W; Carey C; Alava F; Rodríguez-Ferrucci H; Quispe AM
    Lancet Glob Health; 2021 Jul; 9(7):e925-e931. PubMed ID: 34022148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Ivermectin use to prevent COVID-19 during the pandemic in Mato Grosso: cross-sectional home-based study.
    Silva NBLD; Rocha RPDS; Andrade ACS; Terças-Trettel ACP; Muraro AP
    Rev Bras Epidemiol; 2023; 26():e230026. PubMed ID: 37162068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ivermectin for preventing and treating COVID-19.
    Popp M; Reis S; Schießer S; Hausinger RI; Stegemann M; Metzendorf MI; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD015017. PubMed ID: 35726131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Trends in drugs usage for COVID-19 during the first wave of the pandemic in a hospital in Lima, Peru].
    Castro NE; García DR; Rivera MT; Rondán-Guerrero P; García-Rojas F; Taype-Rondan A
    Rev Peru Med Exp Salud Publica; 2021; 38(4):608-614. PubMed ID: 35385014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge and Impact of COVID-19 on Middle-Aged and Older People Living with HIV in Lima, Peru.
    Diaz MM; Cabrera DM; Gil-Zacarias M; Ramirez V; Saavedra M; Cárcamo C; Hsieh E; Garcia PJ
    J Int Assoc Provid AIDS Care; 2021; 20():23259582211056760. PubMed ID: 34870508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial.
    Vallejos J; Zoni R; Bangher M; Villamandos S; Bobadilla A; Plano F; Campias C; Chaparro Campias E; Achinelli F; Guglielmone HA; Ojeda J; Medina F; Farizano Salazar D; Andino G; Ruiz Diaz NE; Kawerin P; Meza E; Dellamea S; Aquino A; Flores V; Martemucci CN; Vernengo MM; Martinez SM; Segovia JE; Aguirre MG
    Trials; 2020 Nov; 21(1):965. PubMed ID: 33234158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High SARS-CoV-2 Seroprevalence in Rural Peru, 2021: a Cross-Sectional Population-Based Study.
    Moreira-Soto A; Pachamora Diaz JM; González-Auza L; Merino Merino XJ; Schwalb A; Drosten C; Gotuzzo E; Talledo M; Arévalo Ramirez H; Peralta Delgado R; Bocanegra Vargas S; Drexler JF
    mSphere; 2021 Dec; 6(6):e0068521. PubMed ID: 34817236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Socioeconomic differences in the reduction of face-to-face contacts in the first wave of the COVID-19 pandemic in Germany.
    Waldhauer J; Beese F; Wachtler B; Haller S; Koschollek C; Pförtner TK; Hoebel J
    BMC Public Health; 2022 Dec; 22(1):2419. PubMed ID: 36564783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 self-testing in Peru: a cross-sectional survey of values and attitudes of the general population.
    Martínez-Pérez GZ; Shilton S; Mallma Salazar PS; Pflucker Oses P; Torres-Slimming PA; Batheja D; Banerji A; Mallery A; Ivanova Reipold E; Carcamo C
    BMJ Open; 2023 Jul; 13(7):e068980. PubMed ID: 37407037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Associated With Drug Consumption Without Scientific Evidence in Patients With Mild COVID-19 in Peru.
    Soriano-Moreno DR; Fernandez-Guzman D; Sangster-Carrasco L; Quispe-Vicuña C; Grados-Espinoza P; Ccami-Bernal F; Morocho-Alburqueque N; Coba-Villan N; Velasquez-Fernandez R; Nieto-Gutierrez W
    J Patient Saf; 2022 Dec; 18(8):e1189-e1195. PubMed ID: 35858482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depressive symptoms among Peruvian adult residents amidst a National Lockdown during the COVID-19 pandemic.
    Antiporta DA; Cutipé YL; Mendoza M; Celentano DD; Stuart EA; Bruni A
    BMC Psychiatry; 2021 Feb; 21(1):111. PubMed ID: 33602157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complicated grief and its relationship with anxiety, depression, and suicidal ideation in older adults in the context of the COVID-19 pandemic in Peru: a cross-sectional analysis.
    Escobar-Agreda S; Romero Albino Z; Contreras PJ; Cuba-Fuentes MS
    BMC Psychiatry; 2023 Dec; 23(1):908. PubMed ID: 38053085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and Factors Associated with Eating Disorders in Military First Line of Defense against COVID-19: A Cross-Sectional Study during the Second Epidemic Wave in Peru.
    Valladares-Garrido MJ; León-Figueroa DA; Picón-Reátegui CK; García-Vicente A; Valladares-Garrido D; Failoc-Rojas VE; Pereira-Victorio CJ
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36833544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.